Literature DB >> 21050114

Use of high-dose 4-hour infusion of doripenem, in combination with fosfomycin, for treatment of carbapenem-resistant Pseudomonas aeruginosa pneumonia.

Anucha Apisarnthanarak, Linda M Mundy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21050114     DOI： 10.1086/657249

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

Review 1.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).

Authors:  Diana Averbuch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Christina Orasch; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

3.  A Real-world Study on Prescription Pattern of Fosfomycin in Critical Care Patients.

Authors:  Kapil G Zirpe; Yatin Mehta; Rahul Pandit; Rajesh Pande; Abhijit M Deshmukh; Saiprasad Patil; Sagar Bhagat; Hanmant Barkate
Journal:  Indian J Crit Care Med       Date:  2021-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.